January 17, 2025: It Is Likely Depo-Provera Will Proceed As An MDL And Not A Class Action It is likely that the lawsuits filed against Pfizer for brain tumor diagnoses following Depo-Provera use will become part of a multidistrict litigation (MDL), rather than a class action lawsuit
Too many negates the medication benefits
Re-evaluations are needed every three months
More than nine million prescriptions were written for semaglutide/weight loss drugs in the last quarter of 2022
Another study published in the NEJM, also supported by Novo Nordisk, showed that patients with preexisting cardiovascular disease who were obese or overweight but did not have diabetes were less likely to experience death from cardiovascular causes, non-fatal myocardial infarctions, or non-fatal strokes while taking semaglutide
That creates a false impression that buying and self-injecting retatrutide in the UK is safe and straightforward